Structured evaluation of unclear dyspnea-An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

"CONFLICTS OF INTEREST STATEMENT Salaheldin Ahmed and Abdulla Ahmed report personal lecture fees from Janssen‐Cilag AB and Nordic Infucare outside the submitted work. Göran Rådegran reports personal lecture fees from Actelion Pharmaceuticals Sweden AB, AOP Health/Orpha Care, Bayer Health Care, GlaxoSmithKline, JanssenCilag AB, MSD and Nordic Infucare outside the submitted work. GR is, and has been primary‐, or co, investigator in; clinical PAH trials for Acceleron, Actelion Pharmaceuticals Sweden AB, Bayer, GlaxoSmithKline, MSD, Pfizer, Janssen‐Cilag AB and United Therapeutics, and in clinical heart transplantation immunosuppression trials for Novartis."

"The work was supported by research grants from Avtal om Läkarutbildning och Forskning (ALF) – the Medical Training and Research Agreement, Skåne University Hospital's foundations and donations, and Go Rad Care AB. The funding organizations played no role in the collection, analysis or interpretation of the data and had no right to restrict the publishing of the manuscript."